News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
AKL’s investigational oral osteoarthritis drug APPA may have a dual effect on senescence with potential in other diseases of aging.
Biotech
Investment
Investment
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Diagnostics
Investment
Investment
Biostarks: home longevity testing that democratizes access to your biological data
Diagnostics
Videos
Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more
Investment
Investment
Retro: A longevity biotech triple-threat?
Biotech
Investment
Investment
Cyclarity: When bad guy cells have a change of heart
Biotech
Investment
Investment
Videos
Solving the Alzheimer’s disease puzzle – one piece at a time
Innovation
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Biotech
Investment
Investment
Videos
Cambrian Bio reveals new pipeline company with focus on AMPK activation
Biotech
Investment
Investment
Longevity investment bulletin: Remedium Bio, GenSight Biologics, SomaLogic and more
Investment
Investment
Health organisations petition FDA to reverse its position on NMN supplements
Economy
Supplements
First longevity clinical study design fetches FDA approval
Biotech
Investment
Investment
New technique for studying mitochondria could enhance neurodegenerative imaging
Innovation
Most Popular
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
Biotech
Investment
Investment
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Diagnostics
Investment
Investment
Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more
Investment
Investment
Retro: A longevity biotech triple-threat?
Biotech
Investment
Investment
Innovation
Solving the Alzheimer’s disease puzzle – one piece at a time
Researchers have uncovered a novel regulatory mechanism in the brain, the malfunctioning of which may contribute to Alzheimer's.
New technique for studying mitochondria could enhance neurodegenerative imaging
Advance offers a new way of investigating diseases – including Alzheimer's and Parkinson's – where mitochondria are disrupted.
Previously unknown cell mechanism could help counter aging
Unknown mechanism of how cells ‘remember’ their identity when they divide – the cells’ so-called epigenetic memory – discovered.
£4m Longitude Prize on Dementia bags 175 entries
Innovations from around the world, including smart glasses and gaming software, aim to help dementia sufferers regain independence.
Economy
Health organisations petition FDA to reverse its position on NMN supplements
How the longevity industry can deliver lives that are healthier – physically and mentally
Off the shelves: Amazon bans NMN products
Formation of Longevity Science Caucus announced
Longevity Summit Dublin 2023 set to be focus for longevity and healthspan research and investment
£4m Longitude Prize on Dementia bags 175 entries
Supplements
Health organisations petition FDA to reverse its position on NMN supplements
ANH and NPA ask the Food and Drug Administration to reverse its position and not exclude NMN from dietary supplement definition.
Supplements
Taking vitamin D could help prevent dementia, study finds
Supplements
Researchers link supplement to reduced biomarkers of Alzheimer’s in the brain
Supplements
New proprietary peptide product is easy on the eye
Supplements
Off the shelves: Amazon bans NMN products
Supplements
Muhdo 2.0 is taking personalized longevity to a new level
Supplements
Buck Institute launches first human clinical trial into ketone body supplementation
Supplements
Why NMN is the supplement to watch in 2023
Supplements
Interrupting the aging cascade
Supplements
Editor's pick
Tally Health wants to move the needle on your longevity
Diagnostics
Using somatic evolution as a human aging timer
Diagnostics
Global longevity investment hit $5.2 billion in 2022
Economy
Investment
A decade of research expands the Hallmarks of Aging from nine to twelve
Economy
Features
Innovation
Investment
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
AKL’s investigational oral osteoarthritis drug APPA may have a dual effect on senescence with potential in other diseases of aging.
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Using novel TruDiagnostic/NADMED test, US healthcare providers can test patients' NAD+ levels at home or in the clinic.
Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more
Longevity investment bulletin, featuring Celmatix, TruDiagnostic, BlueRock, Cyclarity, Retro Bio, Mitrix and Cambrian.
Retro: A longevity biotech triple-threat?
Joe Betts-LaCroix on investing in longevity biotech and Retro’s progress in cellular reprogramming, autophagy, and plasma programs.
Diagnostics
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Biostarks: home longevity testing that democratizes access to your biological data
Seeking consensus on the biomarkers of aging
Biological age estimation using circulating blood biomarkers
Digital markers near-perfect for predicting dementia
Tally Health wants to move the needle on your longevity
Watch now
Cyclarity: When bad guy cells have a change of heart
How Cyclarity is targeting atherosclerosis and giving the body the means to reverse disease from the inside out.
Videos
Biostarks: home longevity testing that democratizes access to your biological data
Videos
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Videos
Bringing biological age tracking to the masses
Videos
Designing a molecule for longevity
Videos
Combining fields will set longevity medicine ahead logarithmically
Videos
Muhdo 2.0 is taking personalized longevity to a new level
Videos
Mapping out the longevity investment landscape
Videos
Keeping it real: SRF’s goal of real longevity therapies for everyone
Videos
Agetech
£4m Longitude Prize on Dementia bags 175 entries
Innovations from around the world, including smart glasses and gaming software, aim to help dementia sufferers regain independence.
Longitude Prize on dementia names expert judging panel
Turing Institute, University of Cambridge and US longevity experts named judges of ground-breaking dementia tech prize.
Five key steps to getting an AgeTech startup funded
Partner at venture capital firm Flint Capital reveals five key steps to funding success for AgeTech startups.
Aging in place is the “holy grail” of AgeTech
Keren Etkin, author of The AgeTech Revolution, talks aging in place and agetech and how they can benefit society at large.
Biotech
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
Retro: A longevity biotech triple-threat?
Cyclarity: When bad guy cells have a change of heart
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Cambrian Bio reveals new pipeline company with focus on AMPK activation
First longevity clinical study design fetches FDA approval
AI/Digital
Bringing biological age tracking to the masses
Biological age estimation using circulating blood biomarkers
Digital markers near-perfect for predicting dementia
£4m Longitude Prize on Dementia bags 175 entries